Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Thalidomide is effective in the treatment
of arteriovenous malformations in the gastrointestinal tract.
Phase:
Phase 2
Details
Lead Sponsor:
Northport Veterans Affairs Medical Center
Collaborators:
Augusta University University of Massachusetts, Worcester